Loading...
Market
How will Eli Lilly's $1.8 billion investment impact its stock price by the end of 2024?
3
Resolution / Starting Odds
Increase by more than 10% • 25%
Increase by 5-10% • 25%
Increase by less than 5% • 25%
No significant change or decrease • 25%
Stock market data, financial reports, and news articles
Story
Eli Lilly to Invest $1.8 Billion in Irish Manufacturing, Creating 150 Jobs in Limerick
Sep 12, 2024, 09:49 AM
Eli Lilly is making a significant investment to expand its manufacturing capabilities in Ireland. The pharmaceutical company announced a $1.8 billion investment across two sites in Ireland, including a further €927 million investment at its facility in Raheen, Limerick. This expansion aims to boost the production of its blockbuster drugs for obesity, diabetes, and Alzheimer's disease, including biologic active ingredients. The investment is expected to create 150 additional jobs at the Limerick facility. Eli Lilly's move underscores its commitment to meeting the growing demand for its in-demand medicines, which help millions of people worldwide.
View original story
Similar markets
Below $900 • 25%
$900 to $950 • 25%
$950 to $1000 • 25%
Above $1000 • 25%
Less than $500 • 25%
$500 to $600 • 25%
$600 to $700 • 25%
More than $700 • 25%
Less than $400 • 25%
$400 to $450 • 25%
$450 to $500 • 25%
More than $500 • 25%
Increase by 0-10% • 25%
Increase by more than 10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
